These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3691426)

  • 1. Biomarkers in neurodevelopmental toxicology.
    Needleman HL
    Environ Health Perspect; 1987 Oct; 74():149-52. PubMed ID: 3691426
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurobehavioral techniques to assess the effects of chemicals on the nervous system.
    Tilson HA; Mitchell CL
    Annu Rev Pharmacol Toxicol; 1984; 24():425-50. PubMed ID: 6375549
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurophysiological studies on workers exposed to lead.
    Triebig G
    Br J Ind Med; 1985 Jul; 42(7):503. PubMed ID: 4016000
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of neurotoxic agents on behavior.
    Johnson BL
    Dev Toxicol Environ Sci; 1983; 11():105-12. PubMed ID: 6376054
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of low level lead exposure on cognitive function in children: a review of behavioral, neuropsychological and biological evidence.
    Banks EC; Ferretti LE; Shucard DW
    Neurotoxicology; 1997; 18(1):237-81. PubMed ID: 9216005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurobehavioral function in children with low blood lead concentrations.
    Min JY; Min KB; Cho SI; Kim R; Sakong J; Paek D
    Neurotoxicology; 2007 Mar; 28(2):421-5. PubMed ID: 16644013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing programs for behavioral toxicity: test guidelines, methodologies and interpretation of data. Boston, November 4-5, 1987. Proceedings.
    Toxicol Ind Health; 1989 Mar; 5(2):157-260. PubMed ID: 2728011
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemical perturbations of development: guiding principles in the assessment of psychogenic and neurogenic abnormalities.
    Mactutus CF
    Proc West Pharmacol Soc; 1985; 28():315-8. PubMed ID: 4070257
    [No Abstract]   [Full Text] [Related]  

  • 9. Human aspects of solvent neurobehavioral effects.
    Neurotoxicology; 1986; 7(4):43-56. PubMed ID: 3808478
    [No Abstract]   [Full Text] [Related]  

  • 10. An introduction to neurobehavioral toxicology.
    Reiter L
    Environ Health Perspect; 1978 Oct; 26():5-7. PubMed ID: 720322
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychotropic drugs--neurotoxicity.
    Zaratzian VL
    Clin Toxicol; 1980 Sep; 17(2):231-70. PubMed ID: 6998646
    [No Abstract]   [Full Text] [Related]  

  • 12. Perspectives in Canadian neuro-psychopharmacology. Proceedings of the eighth annual meeting of the Canadian College of Neuropsychopharmacology. May 5-8, 1985, London, Ontario.
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):463-768. PubMed ID: 4089180
    [No Abstract]   [Full Text] [Related]  

  • 13. [19th annual meeting of the Japanese Society of Neuropsychopharmacology. Fukuoka, 24-25 October 1990 1989. Abstracts].
    Yakubutsu Seishin Kodo; 1990 Mar; 10(1):15-258. PubMed ID: 2220126
    [No Abstract]   [Full Text] [Related]  

  • 14. Warning: nerve poisons at work!
    Polakoff PL
    Occup Health Saf; 1982 Nov; 51(11):15-6, 18. PubMed ID: 7167253
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neurologic behavior of newborn infants after different types of anesthesia in planned cesarean section].
    Iordanov K; Nin'o A
    Akush Ginekol (Sofiia); 1986; 25(2):90-4. PubMed ID: 3728874
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of electromyography in the monitoring of exposure to neurotoxic substances].
    Violante FS; Berardi BM; Raffi GB
    G Clin Med; 1982 Mar; 63(3):154-8. PubMed ID: 7106464
    [No Abstract]   [Full Text] [Related]  

  • 17. Target organ toxicity: nervous system.
    Mitchell CL
    Environ Health Perspect; 1978 Oct; 26():3-4. PubMed ID: 720320
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurobehavioral toxicity of carbon disulfide.
    Wood RW
    Neurobehav Toxicol Teratol; 1981; 3(4):397-405. PubMed ID: 7038525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human behavioural pharmacology.
    Willner P; Oglesby M; Sanger D
    Behav Pharmacol; 1998 Nov; 9(7):477-8. PubMed ID: 9862071
    [No Abstract]   [Full Text] [Related]  

  • 20. The characteristics of an adverse effect: using the example of developing a standard for lead.
    Marcus WL; Cothern CR
    Drug Metab Rev; 1985-1986; 16(4):423-40. PubMed ID: 3915472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.